3-Acetamido-4-phenyl-pyrazol | 62538-15-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 3-Acetamido-4-phenyl-pyrazol
• 英文别名: 3-(N-Acetylamido)-4-phenylpyrazol；N-(4-phenyl-1(2)H-pyrazol-3-yl)-acetamide；N-(4-phenyl-1H-pyrazol-5-yl)acetamide
• CAS: 62538-15-2
• 化学式: C₁₁H₁₁N₃O
• 分子量: 201.228
• InChiKey: NRCCSMDEQBHBTL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  57.8
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-Acetamido-4-phenyl-pyrazol 在 dimethyl sulfide borane 作用下， 生成 3-Ethylamino-4-phenyl-pyrazol
  参考文献：
  名称：

  Synthesis and BZR affinity of pyrazolo[1,5-a]pyrimidine derivatives. part 1: study of the structural features for BZR recognition

  摘要：

  Examination of the pharmacophoric points of the pyrazolo[1,5-a]pyrimidine derivatives, ligands for BZR, previously published led us to the design of a novel class of 3,6-diaryl-4,7-dihydro-pyrazolo[1,5-a]pyrimidin-7-ones and to determine the groups involved in the BZR recognition. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(99)00232-1

文献信息

• [EN] PHENYLACETAMIDO- PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS<br/>[FR] DERIVES PHENYLACETAMIDO-PYRAZOLE ET LEUR UTILISATION COMME AGENTS ANTITUMORAUX
  申请人：PHARMACIA ITALIA SPA

  公开号：WO2002048114A1

  公开（公告）日：2002-06-20

  Phenylacetamido-pyrazoles of Formula (I) and, more particularly, N-(5-cycloalkyl-1H-pyrazol-3-yl) phenylacetamido derivatives, optionally further substituted as reported in the description; or pharmaceutically acceptable salts thereof; are useful in the treatment of cell proliferative disorders, e.g.cancer, associated with an altered cell cycle dependent kinase activity. Formula (I).

  公式（I）中的苯乙酰胺基吡唑，更具体地说，是N-(5-环烷基-1H-吡唑-3-基)苯乙酰胺衍生物，可以进一步按照描述进行取代的衍生物；或其药学上可接受的盐；在治疗细胞增殖性疾病，例如与改变的细胞周期依赖性激酶活性相关的癌症中有用。 公式（I）。
• Phenylacetamido-pyrazole derivatives and their use as antitumor agents
  申请人：——

  公开号：US20040019046A1

  公开（公告）日：2004-01-29

  Phenylacetamido-pyrazoles and, more particularly, N-(5-cycloalkyl-1H-pyrazol-3-yl)phenylacetamido derivatives, optionally further substituted as reported in the description; or pharmaceutically acceptable salts thereof; are useful in the treatment of cell proliferative disorders, e.g. cancer, associated with an altered cell cycle dependent kinase activity.

  苯乙酰胺基吡唑，更具体地说，是N-(5-环烷基-1H-吡唑-3-基)苯乙酰胺衍生物，可选择性地进一步取代，如描述所述；或其药学上可接受的盐；在治疗与细胞周期依赖性激酶活性改变相关的细胞增殖性疾病，例如癌症方面有用。
• PHENYLACETAMIDO-PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS
  申请人：Pharmacia Italia S.p.A.

  公开号：EP1345909A1

  公开（公告）日：2003-09-24
• US6455559B1
  申请人：——

  公开号：US6455559B1

  公开（公告）日：2002-09-24